These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

277 related articles for article (PubMed ID: 39038029)

  • 1. Viral interference between severe acute respiratory syndrome coronavirus 2 and influenza A viruses.
    Gilbert-Girard S; Piret J; Carbonneau J; Hénaut M; Goyette N; Boivin G
    PLoS Pathog; 2024 Jul; 20(7):e1012017. PubMed ID: 39038029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Host Response to Influenza A Virus Interferes with SARS-CoV-2 Replication during Coinfection.
    Oishi K; Horiuchi S; Minkoff JM; tenOever BR
    J Virol; 2022 Aug; 96(15):e0076522. PubMed ID: 35862681
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influenza A(H1N1)pdm09 Virus but Not Respiratory Syncytial Virus Interferes with SARS-CoV-2 Replication during Sequential Infections in Human Nasal Epithelial Cells.
    Fage C; Hénaut M; Carbonneau J; Piret J; Boivin G
    Viruses; 2022 Feb; 14(2):. PubMed ID: 35215988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiviral Activity of Type I, II, and III Interferons Counterbalances ACE2 Inducibility and Restricts SARS-CoV-2.
    Busnadiego I; Fernbach S; Pohl MO; Karakus U; Huber M; Trkola A; Stertz S; Hale BG
    mBio; 2020 Sep; 11(5):. PubMed ID: 32913009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral Interference During Influenza A-SARS-CoV-2 Coinfection of the Human Airway Epithelium and Reversal by Oseltamivir.
    Cheemarla NR; Watkins TA; Mihaylova VT; Foxman EF
    J Infect Dis; 2024 May; 229(5):1430-1434. PubMed ID: 37722683
    [TBL] [Abstract][Full Text] [Related]  

  • 6. SARS-CoV-2 and Influenza A Virus Coinfections in Ferrets.
    Huang Y; Skarlupka AL; Jang H; Blas-Machado U; Holladay N; Hogan RJ; Ross TM
    J Virol; 2022 Mar; 96(5):e0179121. PubMed ID: 34936487
    [TBL] [Abstract][Full Text] [Related]  

  • 7. No evidence of SARS-CoV-2 in hospitalized patients with severe acute respiratory syndrome in five Italian hospitals from 1st November 2019 to 29th February 2020.
    Panatto D; Orsi A; Pennati BM; Lai PL; Mosca S; Bruzzone B; Caligiuri P; Napoli C; Bertamino E; Orsi GB; Manini I; Loconsole D; Centrone F; Pandolfi E; Ciofi Degli Atti ML; Concato C; Linardos G; Onetti Muda A; Raponi M; Piccioni L; Rizzo C; Chironna M; Icardi G
    PLoS One; 2021; 16(12):e0260947. PubMed ID: 34874956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction and antiviral treatment of coinfection between SARS-CoV-2 and influenza in vitro.
    Liu D; Leung KY; Lam HY; Zhang R; Fan Y; Xie X; Chan KH; Hung IF
    Virus Res; 2024 Jul; 345():199371. PubMed ID: 38621598
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and virological impact of single and dual infections with influenza A (H1N1) and SARS-CoV-2 in adult inpatients.
    Zheng J; Chen F; Wu K; Wang J; Li F; Huang S; Lu J; Huang J; Liu H; Zhou R; Huang Z; Meng B; Yuan Z; Wu X
    PLoS Negl Trop Dis; 2021 Nov; 15(11):e0009997. PubMed ID: 34843492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiviral susceptibility of SARS-CoV-2 and influenza viruses from 3 co-infected pediatric patients.
    Takashita E; Ichikawa M; Fujisaki S; Morita H; Nagata S; Miura H; Watanabe S; Hasegawa H; Kawaoka Y
    Int J Infect Dis; 2024 Sep; 146():107134. PubMed ID: 38944411
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity in transmissibility and shedding SARS-CoV-2 via droplets and aerosols.
    Chen PZ; Bobrovitz N; Premji Z; Koopmans M; Fisman DN; Gu FX
    Elife; 2021 Apr; 10():. PubMed ID: 33861198
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical significance and role of coinfections with respiratory pathogens among individuals with confirmed severe acute respiratory syndrome coronavirus-2 infection.
    Trifonova I; Christova I; Madzharova I; Angelova S; Voleva S; Yordanova R; Tcherveniakova T; Krumova S; Korsun N
    Front Public Health; 2022; 10():959319. PubMed ID: 36117597
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Respiratory Syncytial Virus Protects Bystander Cells against Influenza A Virus Infection by Triggering Secretion of Type I and Type III Interferons.
    Czerkies M; Kochańczyk M; Korwek Z; Prus W; Lipniacki T
    J Virol; 2022 Nov; 96(22):e0134122. PubMed ID: 36326278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential Modulation of Innate Immune Responses in Human Primary Cells by Influenza A Viruses Carrying Human or Avian Nonstructural Protein 1.
    Monteagudo PL; Muñoz-Moreno R; Fribourg M; Potla U; Mena I; Marjanovic N; Hartmann BM; Sealfon SC; García-Sastre A; Ramos I; Fernández-Sesma A
    J Virol; 2019 Dec; 94(1):. PubMed ID: 31597767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic influenza viruses and coronaviruses utilize similar and contrasting approaches to control interferon-stimulated gene responses.
    Menachery VD; Eisfeld AJ; Schäfer A; Josset L; Sims AC; Proll S; Fan S; Li C; Neumann G; Tilton SC; Chang J; Gralinski LE; Long C; Green R; Williams CM; Weiss J; Matzke MM; Webb-Robertson BJ; Schepmoes AA; Shukla AK; Metz TO; Smith RD; Waters KM; Katze MG; Kawaoka Y; Baric RS
    mBio; 2014 May; 5(3):e01174-14. PubMed ID: 24846384
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Coinfection by Severe Acute Respiratory Syndrome Coronavirus 2 and Influenza A(H1N1)pdm09 Virus Enhances the Severity of Pneumonia in Golden Syrian Hamsters.
    Zhang AJ; Lee AC; Chan JF; Liu F; Li C; Chen Y; Chu H; Lau SY; Wang P; Chan CC; Poon VK; Yuan S; To KK; Chen H; Yuen KY
    Clin Infect Dis; 2021 Jun; 72(12):e978-e992. PubMed ID: 33216851
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidemiological and Genetic Characteristics of Respiratory Viral Coinfections with Different Variants of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2).
    Trifonova I; Korsun N; Madzharova I; Alexiev I; Ivanov I; Levterova V; Grigorova L; Stoikov I; Donchev D; Christova I
    Viruses; 2024 Jun; 16(6):. PubMed ID: 38932250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Resurgence of influenza with increased genetic diversity of circulating viruses during the 2022-2023 season.
    Korsun N; Trifonova I; Madzharova I; Christova I
    J Med Microbiol; 2024 Jul; 73(7):. PubMed ID: 39073070
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of a multi-recombinase polymerase amplification assay for rapid identification of COVID-19, influenza A and B.
    Liang LG; Zhu MJ; He R; Shi DR; Luo R; Ji J; Cheng LF; Lu XY; Lu W; Liu FM; Wu ZG; Wu NP; Chen H; Chen Z; Yao HP
    J Med Virol; 2023 Jan; 95(1):e28139. PubMed ID: 36089764
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Low prevalence of influenza viruses and predominance of A(H3N2) virus with respect to SARS-CoV-2 during the 2021-2022 season in Bulgaria.
    Korsun N; Trifonova I; Dobrinov V; Madzharova I; Grigorova I; Christova I
    J Med Virol; 2023 Feb; 95(2):e28489. PubMed ID: 36832544
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.